REPL · Nasdaq · CIK 0001737953

Replimune Group, Inc.

Replimune Group, Inc.’s most recent SEC filing in our snapshot is a Form 8-K filed on Sep 16, 2026. Its EDGAR record lists 39 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
—
Net income, FY2026
-$313.9M
Form 4 filings on record, past 12 months
39

Company overview

Legal name (as filed)
Replimune Group, Inc.
Ticker
REPL
SEC Central Index Key (CIK)
0001737953
Business address
WOBURN, MA
State or country of incorporation
DE
Fiscal year ends
March 31
SEC filer category
Non-accelerated filer<br>Smaller reporting company
Position in SEC ticker list
#2357 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from Replimune Group, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
n/aFY2022n/aFY2023n/aFY2024n/aFY2025n/aFY2026
Net income
-$118.0MFY2022-$174.3MFY2023-$215.8MFY2024-$247.3MFY2025-$313.9MFY2026
REPL annual results
ItemFY2022
ended Mar 31, 2022		FY2023
ended Mar 31, 2023		FY2024
ended Mar 31, 2024		FY2025
ended Mar 31, 2025		FY2026
ended Mar 31, 2026
Revenue—————
Net income-$118.0M-$174.3M-$215.8M-$247.3M-$313.9M
Diluted EPS-$2.26-$2.99-$3.24-$3.07-$3.38
Total assets$461.2M$646.6M$487.7M$551.3M$332.4M
Cash and equivalents$105.9M$146.6M$74.5M$111.1M$209.0M

XBRL tags used: netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

REPL latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Jun 29, 202610-KAnnual report· period Mar 31, 2026Document · Index
Aug 14, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Sep 16, 20268-KCharter, bylaws or fiscal year change; Shareholder vote results· period Sep 15, 2026Document · Index
Jul 29, 2026DEF 14AFORM -DEF 14A· period Sep 15, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about Replimune Group, Inc., by form type:

4 ×138-K ×9SCHEDULE 13G ×3SCHEDULE 13G/A ×210-Q ×1S-3ASR ×1SCHEDULE 13D/A ×18-K/A ×1424B5 ×1EFFECT ×1ARS ×1DEFA14A ×1DEF 14A ×1S-3/A ×1PRE 14A ×110-K ×1S-8 ×1
REPL recent filings
FiledFormWhat it isOriginal
Sep 16, 20268-KCharter, bylaws or fiscal year change; Shareholder vote results· period Sep 15, 2026Document · Index
Aug 24, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 20, 2026Document · Index
Aug 19, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 17, 2026Document · Index
Aug 14, 202610-QQuarterly report· period Jun 30, 2026Document · Index
Aug 14, 2026S-3ASRSimplified registration statementDocument · Index
Aug 14, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 14, 20268-KResults of operations· period Aug 14, 2026Document · Index
Aug 12, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026Document · Index
Aug 12, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026Document · Index
Aug 12, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026Document · Index
Aug 12, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 10, 2026Document · Index
Aug 11, 20264Statement of changes in beneficial ownership (insider trade)· period Aug 11, 2026Document · Index
Aug 11, 2026SCHEDULE 13D/AActive beneficial ownership report (over 5%)Document · Index
Aug 11, 20268-K/AOther events· period Aug 9, 2026Document · Index
Aug 10, 20268-KOther events· period Aug 9, 2026Document · Index
Aug 10, 2026424B5424B5Document · Index
Aug 10, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 7, 20268-KOther events· period Aug 6, 2026Document · Index
Aug 7, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Aug 6, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Jul 31, 20268-KOther events· period Jul 30, 2026Document · Index
Jul 30, 20268-KRegulation FD disclosure· period Jul 30, 2026Document · Index
Jul 29, 2026EFFECTEFFECTDocument · Index
Jul 29, 2026ARSARS· period Mar 31, 2026Document · Index
Jul 29, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Jul 29, 2026DEF 14AFORM -DEF 14A· period Sep 15, 2026Document · Index
Jul 24, 2026S-3/ASimplified registration statementDocument · Index
Jul 13, 2026PRE 14APRE 14A· period Sep 15, 2026Document · Index
Jun 29, 202610-KAnnual report· period Mar 31, 2026Document · Index
Jun 29, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Jun 29, 20268-KResults of operations· period Jun 29, 2026Document · Index
Jun 26, 20268-KRegulation FD disclosure· period Jun 26, 2026Document · Index
Jun 3, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 1, 2026Document · Index
May 29, 20268-KRegulation FD disclosure· period May 29, 2026Document · Index
May 21, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
May 20, 20264Statement of changes in beneficial ownership (insider trade)· period May 18, 2026Document · Index
May 20, 20264Statement of changes in beneficial ownership (insider trade)· period May 18, 2026Document · Index
May 20, 20264Statement of changes in beneficial ownership (insider trade)· period May 18, 2026Document · Index
May 20, 20264Statement of changes in beneficial ownership (insider trade)· period May 18, 2026Document · Index
May 20, 20264Statement of changes in beneficial ownership (insider trade)· period May 18, 2026Document · Index

Insider filing activity

39 Form 4 filings appear in Replimune Group, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Biological Products, (No Diagnostic Substances)

All 61 companies in Biological Products, (No Diagnostic Substances)· Companies headquartered in Massachusetts

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0001737953 and XBRL company facts. Replimune Group, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.